Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-08

Clinical Trial Update: Sevoflurane Decreases the Risk of Postoperative Delirium After Cerebral Hypoxemia During Surgery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reports that sevoflurane use during surgery reduces the risk of postoperative delirium in patients who experience cerebral hypox…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sevoflurane (Sevoflurane)

Snippet

Sponsor: Negovsky Reanimatology Research Institute | Conditions: Cerebral Hypoxia, Postoperative Delirium | Phase 4 | Status: UNKNOWN